8-A12B 1 a14-14251_108a12b.htm 8-A12B

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

_____________

 

 

FORM 8-A

_____________

 

FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES
PURSUANT TO SECTION 12(b) OR 12(g) OF THE

SECURITIES EXCHANGE ACT OF 1934

_____________

 

 

JAGUAR ANIMAL HEALTH, INC.

(Exact name of registrant as specified in its charter)

_____________

 

Delaware

(State of incorporation or organization)

 

46-2956775

(I.R.S. Employer Identification No.)

 

 

 

 

 

 

185 Berry Street, Suite 1300

San Francisco, California

(Address of principal executive offices)

 

94107

(Zip Code)

 

Securities to be registered pursuant to Section 12(b) of the Act:

 

 

Title of each class

 

Name of each exchange on which

to be so registered

 

each class is to be registered

 

 

 

Common Stock, par value $0.0001 per share

 

The NASDAQ Stock Market LLC

 

_____________

 

If this form relates to the registration of a class of securities pursuant to Section 12(b) of the Exchange Act and is effective pursuant to General Instruction A.(c), check the following box. x

 

If this form relates to the registration of a class of securities pursuant to Section 12(g) of the Exchange Act and is effective pursuant to General Instruction A.(d), check the following box. o

 

Securities Act registration statement file number to which this form relates: 333-198383

 

Securities to be registered pursuant to Section 12(g) of the Act: None

 


 

Item 1.  Description of Registrant’s Securities to be Registered.

 

Jaguar Animal Health, Inc. (the “Registrant”)  hereby incorporates by reference herein the description of its Common Stock, par value $0.0001 per share, to be registered hereunder, contained under the heading “Description of Capital Stock” in the Registrant’s Registration Statement on Form S-1 (File No. 333-198383),  as originally filed with the Securities and Exchange Commission (the “Commission”) on August 27, 2014, including exhibits, and as amended from time to time thereafter (the “Registration Statement”). In addition, the above-referenced description included in any prospectus relating to the Registration Statement filed with the Commission pursuant to Rule 424(b) under the Securities Act of 1933, as amended, shall be deemed to be incorporated by reference herein.

 

 

Item 2.  Exhibits.

 

In accordance with the “Instructions as to Exhibits” with respect to Form 8-A, no exhibits are required to be filed as part of this registration statement because no other securities of the Registrant are registered on The NASDAQ Stock Market LLC and the securities registered pursuant to this Form 8-A are not being registered pursuant to Section 12(g) of the Securities Exchange Act of 1934, as amended.

 

- 2 -


 

SIGNATURE

 

Pursuant to the requirements of Section 12 of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereto duly authorized.

 

 

 

 

JAGUAR ANIMAL HEALTH, INC.

 

 

 

 

 

 

 

 

 

 

By:

/s/ Lisa A. Conte

 

 

Lisa A. Conte
Chief Executive Officer and President

 

Date: October 30, 2014

 

- 3 -